NovaBridge Biosciences (NBP)
NASDAQ: NBP · Real-Time Price · USD
3.890
0.00 (0.00%)
At close: Jan 23, 2026, 4:00 PM EST
4.008
+0.118 (3.04%)
After-hours: Jan 23, 2026, 7:53 PM EST
NovaBridge Biosciences Market Cap
NovaBridge Biosciences has a market cap or net worth of $448.48 million as of January 23, 2026. Its market cap has increased by 460.59% in one year.
Market Cap
448.48M
Enterprise Value
223.48M
1-Year Change
460.59%
Ranking
Category
Stock Price
$3.89
Market Cap Chart
Since January 17, 2020, NovaBridge Biosciences's market cap has increased from $138.05M to $448.48M, an increase of 224.88%. That is a compound annual growth rate of 21.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 448.48M | -2.26% |
| Dec 31, 2025 | 458.86M | 562.90% |
| Dec 31, 2024 | 69.22M | -56.10% |
| Dec 29, 2023 | 157.68M | -54.60% |
| Dec 30, 2022 | 347.35M | -90.48% |
| Dec 31, 2021 | 3.65B | 9.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Contineum Therapeutics | 474.52M |
| Vanda Pharmaceuticals | 473.36M |
| Anavex Life Sciences | 469.97M |
| Immutep | 465.73M |
| DiaMedica Therapeutics | 455.95M |
| Eupraxia Pharmaceuticals | 455.47M |
| 4D Molecular Therapeutics | 454.80M |
| ADC Therapeutics | 447.20M |